We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Asks Manufacturers of Hip Replacements To Study Failure Rates
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > FDA Asks Manufacturers of Hip Replacements To Study Failure Rates
Medical DevicesOrthopaedics

FDA Asks Manufacturers of Hip Replacements To Study Failure Rates

BarbaraDuck
BarbaraDuck
Share
3 Min Read
SHARE

The point of the study is to find out how fast and how many will fail, what is the failure rate.  We have Johnson and Johnson largely at the head of this investigation for their DePuy failure rates and recalls, and of course they no longer make the product.  As you can see below at the bottom there are others named in the request and there could be more requests generated as the FDA may look into the entire area of implants before they are done.  BD 

The point of the study is to find out how fast and how many will fail, what is the failure rate.  We have Johnson and Johnson largely at the head of this investigation for their DePuy failure rates and recalls, and of course they no longer make the product.  As you can see below at the bottom there are others named in the request and there could be more requests generated as the FDA may look into the entire area of implants before they are done.  BD 

In an unusual move, the Food and Drug Administration has ordered all producers of a popular category of artificial hip to undertake studies of the implants, which have been linked to high early failure rates and severe health effects in some patients.

In a telephone interview on Tuesday, Dr. William H. Maisel, the deputy director for science at the F.D.A.’s Center for Devices and Radiological Health, said the order marks the broadest use of the agency’s authority to conduct studies of devices after approval for sale. He also said that the F.D.A. wanted information about the entire category of implants, not any single manufacturer’s device.

“This is the largest group of studies that we have asked for,” for an approved class of devices, said Dr. Maisel.

Along with the DePuy division of Johnson & Johnson, other major producers of hip implants include Zimmer, Stryker, Biomet and Wright Medical.

Studies Ordered for Makers of Artificial Hips – NYTimes.com

 

More Read

Baby Boomer’s Guide to Dealing with Knee Problems
Patient Centricity and Healthcare Marketing
The Key Benefits Of Investing In Medical Alert Systems
FDA Has A New Training Program for Medical Device Reviewers
Amazing Health Tech in Surprising Places: A Report from Azerbaijan
   

TAGGED:FDAmedical devicesorthopaedics
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

The Case for Proactive Nutrient Support and Where IV Therapy Fits In -- AI-generated illustration
The Case for Proactive Nutrient Support and Where IV Therapy Fits In
Health Therapies
October 5, 2026
Biofeedback Technology in Addiction Treatment: What the Evidence Shows So Far -- AI-generated illustration
Biofeedback Technology in Addiction Treatment: What the Evidence Shows So Far
Addiction Addiction Recovery
September 28, 2026
Charity Care Is Written Into Hospital Policy. It Rarely Makes It Onto the Bill. -- AI-generated illustration
Charity Care Is Written Into Hospital Policy. It Rarely Makes It Onto the Bill.
Business Hospital Administration
September 25, 2026
A Global Perspective on Medicine: Lessons Learned Across Borders -- AI-generated illustration
A Global Perspective on Medicine: Lessons Learned Across Borders
Medicines
September 23, 2026

You Might also Like

x-ray dosimeter
DiagnosticsMedical DevicesRadiologyTechnology

X-Ray Dosimeter Improves Radiation Dose Management in Real-Time: Or, How a Little Badge Provides Real-Time Radiation Dose Data

April 1, 2014

The Case for Regulating EMRs and the New FDA MDDS Rules

February 18, 2011

Digital Radiology Comes of Age

February 15, 2012
nanopatch vaccine
Medical DevicesMedical InnovationsTechnology

Painless Vaccinations Coming Soon!

September 12, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?